Addictions Training Program

MUHC Addictions Unit Training Program 2019

Treating Substance Dependence and Mental Illness: Tools for Practitioners

The 2 day Addictions Training Program will be presented by staff members from the Addictions Unit, McGill University Health Centre (MUHC). The program is open to health practitioners, broadly defined as clinicians currently employed within a health-care setting, with a professional degree or certification (medicine, nursing, psychology, social work, occupational therapy). The objective of the training program is to provide practical tools that will facilitate the detection, screening, and assessment of clients with substance use disorders. The sessions are designed to encourage the adoption of evidence-based practices, including very brief interventions. Decision making in relation to treatment planning and referral will be addressed. The sessions will include didactic material, as well as case discussions and practical learning exercises. Film excerpts will be used to demonstrate motivational approaches to screening and brief interventions in a variety of practice environments. The intended end-users are health care professionals that are likely to encounter drug/alcohol abusers in their daily practice.

  • Dates: December 9th and 11th, 2019, from 8:30am to 5:00pm (14 hours total)
    Location of Sessions: South Seminar Room, P1.082
    Allan Memorial Institute, McGill University Health Centre
    1025 Pine Avenue West, Montreal H3A 1A1

The Allan Memorial Institute is located at the top of Peel Street, just above Pine Avenue. Note that parking is available adjacent to the Institute, for a $25 fee. There is very limited street parking (please read posted signs).

Program Information
Contact Dr. Kathryn Gill by fax at 514-934-8262 or email at [email protected]

Program Registration
Contact Ms. Lyne Marchand by fax at 514-934-8262, by email at [email protected] or by phone at 514-934-1934 x42066. The registration form is also available at http://muhc.ca/addictions_unit/page/addictions-training-program-treating-substance-dependence-and-mental-illness-tools-practitioner

Continuing Education Credits
This event will be accredited from the Ordre des psychologues du Québec - No de reconnaissance: Formation continue en psychothérapie, and applications are in process for certification from the Canadian Addiction Counsellors Certification Federation - 14 core ceu's. Review for CME as an Accredited Group Learning Activity as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada is also in progress. Each health professional should claim only those hours of credit that he/she actually spent at the educational activity. In order to receive a certificate at the end of the course, it is important to sign an attendance sheet and hand in an evaluation form at each session. The sign-in sheets and evaluation forms will be made available at the start of each session.

 

A full outline will be posted in September 2019

 

Outline of Sessions

Registration form will be posted in September 2019

 

1. Session 1 - October 28 “What Clinicians Need to Know about Addictions”

Part 1 - Didactic Session (Dr. Kathryn Gill, 1 hour)

The session will focus on conceptual models of addiction, pharmacology and phenomenology. Film excerpts will be used at various points in the session. The session will address the following questions:

a) What is addiction? Focus on the signs and symptoms of addiction and how does it develops

b) Is addiction a brain disorder? Opinions from NIDA and the WHO

c) What are the effects of drugs/alcohol on the brain? A brief look at dopamine and GABA, drug-induced deficits in the brain circuitry controlling thinking and behaviour, and research using brain imaging techniques

d) Are some individuals more vulnerable to addiction?

Part 2 – Workshop/Discussion Session (Dr. Kathryn Gill, Dr. Juan Negrete)

Case-based learning – group discussion of addiction (symptoms, behaviours, sequelae, diagnosis, comorbidities)

2. Session 2 - November 4 "Screening and Assessment"

Part 1 - Didactic Session (Dr. Kathryn Gill, 1 hour)

Methods for screening and assessment for drug/alcohol abuse in a variety of practice situations will be presented. Discussion of various screening tools including the WHO ASSIST and the DEBA-AD, as well as assessment instruments (Addiction Severity Index – lite and full versions). Film excerpts will be used to demonstrate motivational approaches to screening/assessing patients in several practice environments.

Part 2 – Workshop/Discussion Session (Dr. Kathryn Gill, Dr. Gail Gauthier)

Group exercise –the class will view a video interview designed to screen a patient for substance use/abuse using the ASSIST instrument. Participants will score the instrument during the video and discussion will focus on providing feedback that is appropriate for various levels of use, abuse and dependence, taking psychosocial factors into account.

3. Session 3 - November 11 "Approach to Concurrent Disorders 1"

Part 1- Didactic Session (Dr. Dara Charney, 1 hour)

This session will address issues related to comorbidity between substance dependence and other mental disorders including depression and anxiety. The didactic component will explore assessment, diagnosis and differential diagnosis, including information on how to tease out overlapping phenomenology (e.g. withdrawal agitation vs. anxiety). The effects of drugs/alcohol on psychiatric symptomatology, course and response to treatment will be discussed.

Part 2 – Workshop (Dr. Dara Charney)

Case-based learning - group discussion of participant’s cases. NB. – please bring brief case summaries to session 2 in order to allow Dr. Charney to prepare for the group discussion.

Summaries should include information on drug use, presenting problem, treatment history if available, and key questions/topic for discussion.

4. Session 4 - November 18 "Approach to Concurrent Disorders 2"

Part 1- Didactic Session (Dr. Ron Fraser, 1 hour)

The didactic component of this session will explore assessment, diagnosis and differential diagnosis for comorbidity related to psychosis and personality disorders. Information on how to tease out overlapping phenomenology (e.g. drug-induced anergia or apathy vs. anhedonia or blunted affect) will be presented. Course and response to treatment will be discussed, along with information on when to refer to specialized psychiatric treatment.

Part 2 – Workshop (Dr. Ron Fraser)

Case-based learning - group discussion of participant’s cases. NB. – please bring brief case summaries to session 3 that include information on drug use, presenting problem, treatment history if available, and key questions/topic for discussion.

5. Session 5 - November 25 "Brief Interventions (BI)"

Part 1 – Didactic Session (Dr. Gail Gauthier, 1 hour)

Structured Brief Intervention - description of a 5 session BI including key components, building motivation (education, feedback, cost/benefit analysis), goal setting, developing coping skills (identifying and handling triggers), drink/drug refusal skills including dealing with cravings and relapse prevention. Demonstration of BI sessions and skill set will be provided throughout, based on videotapes of therapy sessions conducted with an actor.

Part 2 – Workshop (Dr. Gail Gauthier, Dr. Kathryn Gill)

Case-based learning and small group practice - taking elements of a BI session and applying to a case that will be provided by the instructors.

6. Session 6 - December 2 "Treatment Planning/Referral and Wrap-up Session"

Part 1 – Didactic Session (Dr. Gail Gauthier, 1 hour)

Treatment planning – Using a decision tree discussion will bring together all aspects of the course from consideration of physical dependence to concurrent disorders in order to plan treatment. Discussion will focus on who can be treated using a brief intervention, compared to those that should be referred to specialized addiction or psychiatric treatment. Facilitated referral to inpatient and outpatient treatment centres in Quebec will be discussed, along with information on the MUHC Addictions Unit program, and peer support groups.

Part 2 – Discussion/Workshop (Dr. Gail Gauthier, Dr. Kathryn Gill)

Case-based learning – small group discussion of participant’s cases in order to apply the decision-making algorithm. NB. – participants will bring brief case summaries to discuss treatment planning (summaries should include information on symptoms, behaviours, comorbidities, previous and current treatments, medications).

Faculty from the Addictions Unit, MUHC

The Addictions Unit: http://muhc.ca/addictions_unit/profile/addictions-unit The Griffith Edwards Centre is administered as part of the MUHC out-patient Psychiatry department and is officially designated as an English language facility--serving the greater Montreal region. It is a hospital-based addictions service that provides a continuum of care for adults with drug/alcohol and mental health disorders including medical detoxification conducted within the inpatient psychiatry unit at the Montreal General Hospital.

Dara Charney M.D., FRCP(C)
Dr. Charney is a staff Psychiatrist at the Addictions Unit, the Director of the McGill RUIS Addiction Program, and an Associate Professor, Department of Psychiatry, McGill University. Her clinical and research work is conducted at the Addictions Unit where she initiated a number of clinical trials and prospective treatment outcome studies with substance use disorder clients, with a particular emphasis on "dual disorder" clients. She has received research funding from the MUHC Research Institute, FRSQ and CIHR, as well as salary awards from both the MUHC Research Institute and FRSQ.

Ron Fraser M.D., FRCP(C)
Dr. Fraser is a staff Psychiatrist at the Addictions Unit and the Head of the MUHC Inpatient Detoxification Service, and an Associate Professor, Department of Psychiatry, McGill University. He completed his residency training in psychiatry at McGill University, as well as a fellowship in Addictions Psychiatry, studying heroin dependence and detoxification techniques. In addition, he runs a long term treatment program for clients with Borderline Personality Disorder at the McGill University Health Centre.

Gail Gauthier Ph.D.
Dr. Gauthier is the former Clinical Director of the Addictions Unit, now in private practice in Montreal. She has a Master’s degree in Counselling Psychology from McGill University, and is a member of the Order of Psychologists of Quebec. She completed an internship in cognitive behavioural therapy at the Montreal General Hospital Behaviour Therapy Service, where she specialized in the treatment of anxiety and eating disorders. She obtained her Ph.D. in Psychiatry at McGill University. Dr. Gauthier has conducted research examining outcomes of therapy for addiction, including factors associated with treatment retention, and treatment comparisons of brief intervention and standard therapy. Her current clinical work is individual and group therapy with clients with substance use and mental health disorders, and her therapeutic expertise is in cognitive behavioural, psychoeducational, and humanistic approaches.

Kathryn Gill Ph.D.
Dr. Gill is the Director of Research at the Addictions Unit and an Associate Professor in the Department of Psychiatry and member of the Division of Transcultural Psychiatry at McGill University. She obtained her Ph.D in psychology, and conducted post-doctoral studies at the Alcohol Research Centre, and the Addiction Research and Treatment Services of the University of Colorado. She divides her time between working at the Addictions Unit treating patients with drug- and alcohol dependence using a combination of group and individual CBT-oriented psychotherapy, teaching at McGill University and conducting research. The clinical research program includes projects on the clinical predictors of treatment outcome, opioid dependence and knowledge translation. She has received research funding from the MUHC Research Institute, CQRS, FRSQ, SSHRC, FQRSC and CIHR, as well as salary awards from both the MUHC Research Institute and FRSQ.

Juan C. Negrete M.D, Dip. Psych., CSPQ, FRCP (C)
Juan C. Negrete received his medical degree from the University of Tucuman (Argentina) and completed training in Psychiatry at McGill University. Dr. Negrete is a Professor Emeritus in the Department of Psychiatry at McGill University. Dr Negrete founded the Addictions Unit of the McGill University Health Centre/Montreal General Hospital in 1980 and was the Director of the Unit until 1995. He is currently a Senior Consultant at the Addictions Unit. He also founded the Concurrent Disorders Program at the Centre for Addiction and Mental Health (CAMH) in Toronto and became its first medical director between 1996 and 2000.

Jorge Palacios-Boix M.D., FRCP(C)
Dr. J. Palacios-Boix is the Director of the Addictions Unit and an Associate Professor in the Department of Psychiatry at McGill University. He is a medical doctor who trained in Psychiatry at McGill University and Dalhousie University, specializing in Addictions Psychiatry, Group Psychotherapy and Mood Disorders. He obtained further training at the Canadian Institute of Psychoanalysis. He is currently a Training and Supervising Psychoanalyst at the Canadian Institute of Psychoanalysis, and President-elect, Canadian Psychoanalytic Society.

Outline of Sessions

1. Session 1 - October 28 “What Clinicians Need to Know about Addictions”

Part 1 - Didactic Session (Dr. Kathryn Gill, 1 hour)The session will focus on conceptual models of addiction, pharmacology and phenomenology. Film excerpts will be used at various points in the session. The session will address the following questions:a) What is addiction? Focus on the signs and symptoms of addiction and how does it developsb) Is addiction a brain disorder? Opinions from NIDA and the WHOc) What are the effects of drugs/alcohol on the brain? A brief look at dopamine and GABA, drug-induced deficits in the brain circuitry controlling thinking and behaviour, and research using brain imaging techniquesd) Are some individuals more vulnerable to addiction?

Part 2 – Workshop/Discussion Session (Dr. Kathryn Gill, Dr. Juan Negrete)Case-based learning – group discussion of addiction (symptoms, behaviours, sequelae, diagnosis, comorbidities)

2. Session 2 - November 4 "Screening and Assessment"

Part 1 - Didactic Session (Dr. Kathryn Gill, 1 hour)Methods for screening and assessment for drug/alcohol abuse in a variety of practice situations will be presented. Discussion of various screening tools including the WHO ASSIST and the DEBA-AD, as well as assessment instruments (Addiction Severity Index – lite and full versions). Film excerpts will be used to demonstrate motivational approaches to screening/assessing patients in several practice environments.

Part 2 – Workshop/Discussion Session (Dr. Kathryn Gill, Dr. Gail Gauthier) Group exercise –the class will view a video interview designed to screen a patient for substance use/abuse using the ASSIST instrument. Participants will score the instrument during the video and discussion will focus on providing feedback that is appropriate for various levels of use, abuse and dependence, taking psychosocial factors into account.

3. Session 3 - November 11 "Approach to Concurrent Disorders 1" 

Part 1- Didactic Session (Dr. Dara Charney, 1 hour)This session will address issues related to comorbidity between substance dependence and other mental disorders including depression and anxiety. The didactic component will explore assessment, diagnosis and differential diagnosis, including information on how to tease out overlapping phenomenology (e.g. withdrawal agitation vs. anxiety). The effects of drugs/alcohol on psychiatric symptomatology, course and response to treatment will be discussed.

Part 2 – Workshop (Dr. Dara Charney)Case-based learning - group discussion of participant’s cases. NB. – please bring brief case summaries to session 2 in order to allow Dr. Charney to prepare for the group discussion. Summaries should include information on drug use, presenting problem, treatment history if available, and key questions/topic for discussion.

4. Session 4 - November 18 "Approach to Concurrent Disorders 2" Part 1- Didactic Session (Dr. Ron Fraser, 1 hour)The didactic component of this session will explore assessment, diagnosis and differential diagnosis for comorbidity related to psychosis and personality disorders. Information on how to tease out overlapping phenomenology (e.g. drug-induced anergia or apathy vs. anhedonia or blunted affect) will be presented. Course and response to treatment will be discussed, along with information on when to refer to specialized psychiatric treatment.

Part 2 – Workshop (Dr. Ron Fraser)Case-based learning - group discussion of participant’s cases. NB. – please bring brief case summaries to session 3 that include information on drug use, presenting problem, treatment history if available, and key questions/topic for discussion.5.

Session 5 - November 25 "Brief Interventions (BI)" Part 1 – Didactic Session (Dr. Gail Gauthier, 1 hour)

Structured Brief Intervention - description of a 5 session BI including key components, building motivation (education, feedback, cost/benefit analysis), goal setting, developing coping skills (identifying and handling triggers), drink/drug refusal skills including dealing with cravings and relapse prevention. Demonstration of BI sessions and skill set will be provided throughout, based on videotapes of therapy sessions conducted with an actor.

Part 2 – Workshop (Dr. Gail Gauthier, Dr. Kathryn Gill)Case-based learning and small group practice - taking elements of a BI session and applying to a case that will be provided by the instructors.6.

Session 6 - December 2 "Treatment Planning/Referral and Wrap-up Session"Part 1 – Didactic Session (Dr. Gail Gauthier, 1 hour)

Treatment planning – Using a decision tree discussion will bring together all aspects of the course from consideration of physical dependence to concurrent disorders in order to plan treatment. The discussion will focus on who can be treated using a brief intervention, compared to those that should be referred to specialized addiction or psychiatric treatment. Facilitated referral to inpatient and outpatient treatment centres in Quebec will be discussed, along with information on the MUHC Addictions Unit program, and peer support groups.

Part 2 – Discussion/Workshop (Dr. Gail Gauthier, Dr. Kathryn Gill)Case-based learning – small group discussion of participant’s cases in order to apply the decision-making algorithm. NB. – participants will bring brief case summaries to discuss treatment planning (summaries should include information on symptoms, behaviours, comorbidities, previous and current treatments, medications).

Faculty from the Addictions Unit, MUHC

The Addictions Unit: http://muhc.ca/addictions_unit/profile/addictions-unit The Griffith Edwards Centre is administered as part of the MUHC out-patient Psychiatry department and is officially designated as an English language facility--serving the greater Montreal region. It is a hospital-based addictions service that provides a continuum of care for adults with drug/alcohol and mental health disorders including medical detoxification conducted within the inpatient psychiatry unit at the Montreal General Hospital.

Dara Charney M.D., FRCP(C)
Dr. Charney is a staff Psychiatrist at the Addictions Unit, the Director of the McGill RUIS Addiction Program, and an Associate Professor, Department of Psychiatry, McGill University. Her clinical and research work is conducted at the Addictions Unit where she initiated a number of clinical trials and prospective treatment outcome studies with substance use disorder clients, with a particular emphasis on "dual disorder" clients. She has received research funding from the MUHC Research Institute, FRSQ and CIHR, as well as salary awards from both the MUHC Research Institute and FRSQ.

Ron Fraser M.D., FRCP(C)
Dr. Fraser is a Staff Psychiatrist at the Addictions Unit and the Head of the MUHC Inpatient Detoxification Service, and an Associate Professor, Department of Psychiatry, McGill University. He completed his residency training in psychiatry at McGill University, as well as a fellowship in Addictions Psychiatry, studying heroin dependence and detoxification techniques. In addition, he runs a long term treatment program for clients with Borderline Personality Disorder at the McGill University Health Centre.

Gail Gauthier Ph.D.
Dr. Gauthier is the former Clinical Director of the Addictions Unit, now in private practice in Montreal. She has a Master’s degree in Counselling Psychology from McGill University, and is a member of the Order of Psychologists of Quebec. She completed an internship in cognitive behavioural therapy at the Montreal General Hospital Behaviour Therapy Service, where she specialized in the treatment of anxiety and eating disorders. She obtained her Ph.D. in Psychiatry at McGill University. Dr. Gauthier has conducted research examining outcomes of therapy for addiction, including factors associated with treatment retention, and treatment comparisons of brief intervention and standard therapy. Her current clinical work is individual and group therapy with clients with substance use and mental health disorders, and her therapeutic expertise is in cognitive behavioural, psychoeducational, and humanistic approaches.

Kathryn Gill Ph.D.
Dr. Gill is the Director of Research at the Addictions Unit and an Associate Professor in the Department of Psychiatry and member of the Division of Transcultural Psychiatry at McGill University. She obtained her Ph.D in psychology, and conducted post-doctoral studies at the Alcohol Research Centre, and the Addiction Research and Treatment Services of the University of Colorado. She divides her time between working at the Addictions Unit treating patients with drug- and alcohol dependence using a combination of group and individual CBT-oriented psychotherapy, teaching at McGill University and conducting research. The clinical research program includes projects on the clinical predictors of treatment outcome, opioid dependence and knowledge translation. She has received research funding from the MUHC Research Institute, CQRS, FRSQ, SSHRC, FQRSC and CIHR, as well as salary awards from both the MUHC Research Institute and FRSQ.

Juan C. Negrete M.D, Dip. Psych., CSPQ, FRCP (C)
Juan C. Negrete received his medical degree from the University of Tucuman (Argentina) and completed training in Psychiatry at McGill University. Dr. Negrete is a Professor Emeritus in the Department of Psychiatry at McGill University. Dr Negrete founded the Addictions Unit of the McGill University Health Centre/Montreal General Hospital in 1980 and was the Director of the Unit until 1995. He is currently a Senior Consultant at the Addictions Unit. He also founded the Concurrent Disorders Program at the Centre for Addiction and Mental Health (CAMH) in Toronto and became its first medical director between 1996 and 2000.

Jorge Palacios-Boix M.D., FRCP(C)
Dr. J. Palacios-Boix is the Director of the Addictions Unit and an Associate Professor in the Department of Psychiatry at McGill University. He is a medical doctor who trained in Psychiatry at McGill University and Dalhousie University, specializing in Addictions Psychiatry, Group Psychotherapy and Mood Disorders. He obtained further training at the Canadian Institute of Psychoanalysis. He is currently a Training and Supervising Psychoanalyst at the Canadian Institute of Psychoanalysis, and President-elect, Canadian Psychoanalytic Society.

MUHC Addictions Unit Training Program Treating Substance Dependence and Mental Illness: Tools for Practitioners

Accreditation: This course will be an accredited CME activity for a total of 18 credits. All participants must sign the attendance sheet available on site in order to receive accreditation. A certificate of attendance will be distributed to all participants after the course.

Cancellation: For written cancellations received on or before November 25, 2019 an amount of $50 will be retained. After December 1, NO REFUND will be issued.

The Allan Memorial Institute is located at the top of Peel Street, just above Pine Avenue. Note that parking is available adjacent to the Institute, for a fee. There is very limited street parking (please read posted signs).

GST# - 10750-8160-PG-0001

PST# - 1006116325-RS-0001